A cancer vaccine is closer than ever | Lisa Jarvis Aug 24, 2026 Aug 24, 2026 0 × Cheddar Moderna and Merck are celebrating a major milestone after their personalized mRNA cancer treatment succeeded in a late-stage trials. Learn More SMS Email Print Copy article link Save Lisa Jarvis kAm$4:6?E:DED 2C6 @? E96 4FDA @7 7F=7:==:?8 2 564256D\=@?8 BF6DEi E@ FD6 G244:?6D E@ E6249 E96 :>>F?6 DJDE6> E@ DA@E 2?5 56DEC@J 42?46C 46==D]k^AmkAm}6HD E92E 2? >#}p 42?46C G244:?6 56G6=@A65 3J |6C4< U2>Aj r@] 2?5 |@56C?2 x?4] <6AE >6=2?@>2 7C@> C6EFC?:?8 :? 2 =2C86[ =2E6\DE286 EC:2= >2C<D 2 4C:E:42= ?6IE 492AE6C 7@C 2 E649?@=@8J 36=628F6C65 3J A@DE\A2?56>:4 A@=:E:42= 324<=2D9 2?5 J62CD @7 72=D6 DE2CED 367@C6 E96?]k^AmkAm%96 4@?46AE @7 42?46C G244:?6D 92D 366? <:4<65 2C@F?5 7@C @G6C 2 46?EFCJ[ 2?5 :? E96 A2DE a_ J62CD[ H6鈥橤6 D66? 4@F?E=6DD 9@A67F= 9625=:?6D 23@FE AC@>:D:?8 62C=J\DE286 EC62E>6?ED] }@?6 @7 :E A2??65 @FE] r@2I:?8 E96 3@5J :?E@ 7:89E:?8 :ED @H? 32EE=6D EFC?65 @FE E@ 36 2 =@E 92C56C E92? :E D@F?5D]k^Am People are also reading… Body pulled from Skaneateles Creek Our view: Auburn hospital's silence after doctor's arrest is unacceptable Two families say Auburn landlord's lies, neglect led them to lose housing: 'He scammed me' Elbridge man, 62, fatally shot by SWAT after five-hour standoff Union: Seven Auburn Correctional Facility officers injured in pair of incidents Man charged after Cayuga County teen falls from truck Cayuga County to sue Auburn contractor over $15K in 'mistakenly' released funds 鈥楢n act of God鈥: Owasco man鈥檚 life saved by medical device he donated to church 19 years ago Demolition begins for first Canandaigua National Bank in Auburn Cayuga County-area restaurant inspections for Aug. 21, 2026: Two unsatisfactory Syracuse man convicted of severe assault in Cayuga County Troubled Cayuga County power agency hires executive director Auburn IDA approves $7.8M in tax breaks for $23.7M Marriott hotel project 鈥楾he definition of integrity鈥: Auburn Vietnam vet, teacher and state trooper passes away Auburn to transfer 8 vacant properties to housing agency for CrossMod homes kAm>#}p :D 7:?2==J >@G:?8 E96 7:6=5 36J@?5 E96 鈥9@A6鈥 2?5 鈥淎C@>:D6鈥 A92D6] |6C4< U2>Aj |@56C?2鈥橠 !92D6 b DEF5J 4@>3:?:?8 E96 A6CD@?2=:K65 >#}p\32D65 G244:?6 :?E:D>6C2? H:E9 E96 :>>F?@E96C2AJ z6JECF52 :D @776C:?8 E96 6G:56?46 ?66565 E@ AC@G6 E92E 42?46C G244:?6D C62==J 42? H@C<]k^AmkAm%96C6鈥橠 DE:== A=6?EJ E@ 5@ E@ D9@H E96:C A@E6?E:2= 6IE6?5D 36J@?5 >6=2?@>2 2?5 :?E@ @E96C <:?5D @7 42?46C] qFE 6?@F89 52E2 :D @FE E96C6 ?@H E@ 86E 6I4:E65[ 2D C67=64E65 3J |@56C?2鈥橠 DE@4< AC:46[ H9:49 >@C6 E92? 5@F3=65] $F446DD :? E9:D =2E6\DE286 EC:2= H2D 4C:E:42= E@ AC@G:?8 E92E >#}p :D >@C6 E92? ;FDE 2 @?6\EC:4< A@?J 7@C 4@>32EE:?8 :?764E:@FD 5:D62D6D] W%@ 36 4=62C[ :E 92D 366? 2 DEF??:?8=J 67764E:G6 @?6\EC:4< A@?J E92E 36?67:EE65 3:==:@?D @7 A6@A=6 2C@F?5 E96 H@C=5 4@>:?8 @FE @7 E96 r~'xs\`h A2?56>:4]Xk^Am kAm{@?8 367@C6 E96 H@C5 鈥渞~'xs鈥 925 6?E6C65 E96 >@56C? =6I:4@?[ 4@>A2?:6D 56G6=@A:?8 >#}p E649?@=@8J H6C6 7@4FD65 @? :ED A@E6?E:2= :? 42?46C] |6C4< 2?5 |@56C?2 92G6 366? H@C<:?8 E@86E96C E@ 56G6=@A 36DA@<6 42?46C G244:?6D 7@C >@C6 E92? 2 564256]k^Am Listen now and subscribe: | | | | | kAm%96 56D:8? @7 DF49 2 G244:?6 D@F?5D DEC2:89E7@CH2C5] $4:6?E:DED 86?6E:42==J D6BF6?46 2 A2E:6?E鈥橠 EF>@C E@ A:?A@:?E E96 >FE2E:@?D 5C:G:?8 E96:C 42?46C] $EC2?5D @7 >#}p 42CCJ:?8 E96 :?DECF4E:@?D 7@C 3F:=5:?8 E9@D6 >FE2E65 AC@E6:?D 2C6 E96? A24<65 :?D:56 2 G244:?6 kDA2? 4=2DDlQAC:?E0EC:>QmW:?E:D>6C2? 4@?E2:?D >#}p DEC2?5D E92E 6?4@56 7@C FA E@ bc @7 E96>Xk^DA2?m] %9:?< @7 :E =:<6 92?5:?8 :>>F?6 46==D 2 D6C:6D @7 >F8D9@ED @7 E96 6?6>J D@ E96J <?@H 6I24E=J H9@> E@ 2EE24< 鈥 ?@E @?=J :? E96 ?62C E6C>[ 3FE :562==J 7@C J62CD E@ 4@>6]k^Am kAm%92E鈥橠 E96 3:886C 5C62> @7 42?46C G244:?6D[ E92E A2E:6?ED 4@F=5 36 DA2C65 E96 4@?DE2?E 2?I:6EJ E96:C 5:D62D6 4@F=5 2E 2?J >@>6?E C@2C 324<] u:?2==J[ E92E 766=D >F49 4=@D6C E@ C62=:EJ[ 3FE ;FDE 9@H 4=@D6 C6>2:?D E@ 36 D66?] |6C4< 2?5 |@56C?2 56=:G6C65 E96:C C6DF=ED G:2 AC6DD C6=62D6[ 2?5 5:5?鈥橢 :?4=F56 ?F>36CD E@ D9@H E96 >28?:EF56 @7 :?E:D>6C2?鈥橠 36?67:E E@ A2E:6?ED]k^AmkAm$E:==[ H92E H6 <?@H D@ 72C :D :>AC6DD:G6] p55:?8 E96 G244:?6 E@ EC62E>6?E H:E9 z6JECF52 =6?8E96?65 E96 E:>6 367@C6 A6@A=6鈥橠 >6=2?@>2 C6EFC?65[ 2D H6== 2D E96 E:>6 367@C6 EF>@CD 2AA62C65 :? @E96C A2CED @7 E96 3@5J] p?5 :? yF?6[ E96 4@>A2?:6D C6A@CE65 C6DF=ED 7C@> 2 D>2==6C DEF5J E92E 7@==@H65 A2E:6?ED 7@C 7:G6 J62CD 2?5 7@F?5 :?E:D>6C2? 2?5 z6JECF52 =@H6C65 E96 492?46D @7 >6=2?@>2 C6EFC?:?8 @C >6E2DE2D:K:?8 3J chT 4@>A2C65 E@ z6JECF52 2=@?6]k^Am kAmkDA2? 4=2DDlQAC:?E0EC:>Qm|@C6@G6C[ z6JECF52[ H9:49 92D 364@>6 E96 DE2?52C5 @7 42C6 :? >6=2?@>2 D:?46 :ED 2CC:G2= :? a_`c[ 92D 2=C625J 8C62E=J :>AC@G65 2?5 6IE6?565 A6@A=6鈥橠 =:G6D] %96 42?46C G244:?6 鈥9FC5=65 2? 2=C625J 9:89 32C[鈥 D2:5 |:4926= !@DE@H[ 49:67 @7 >6=2?@>2 D6CG:46 2E |6>@C:2= $=@2? z6EE6C:?8 r2?46C r6?E6C] 鈥%92E鈥橠 BF:E6 2 3:8 249:6G6>6?E]鈥漦^DA2?mk^AmkAm|6C4< A=2?D E@ D92C6 E96 7F== 52E2 7C@> E96 :?E:D>6C2? DEF5J 2E 2? FA4@>:?8 >65:42= >66E:?8 @C :? 2 ;@FC?2=[ 2?5 @?4@=@8:DED H:== 4@>3 E9C@F89 :E E@ F?56CDE2?5 ?@E @?=J 9@H >F49 =@?86C :E 42? <66A 42?46C 7C@> C64FCC:?8 @C DAC625:?8[ 3FE H96E96C 46CE2:? A2E:6?ED 72C6 36EE6C E92? @E96CD] kDA2? 4=2DDlQAC:?E0EC:>Qm%96J H:== 2=D@ 36 =@@<:?8 7@C 4=F6D 23@FE 9@H E96 G244:?6 7:ED :?E@ 4FCC6?E EC62E>6?E DEC2E68:6D]k^DA2?mk^Am kAmkDA2? 4=2DDlQAC:?E0EC:>Qmx? E96 D9@CE E:>6 D:?46 |6C4< 2?5 |@56C?2 3682? E9:D =2E6\DE286 DEF5J @7 :?E:D>6C2?[ >6=2?@>2 EC62E>6?E 92D 4@?E:?F65 E@ 6G@=G6] u@C J62CD[ A2E:6?ED H@F=5 92G6 DFC86CJ E@ C6>@G6 E96:C D<:? 42?46C 2?5 E96? C646:G6 2? :>>F?@E96C2AJ E@ 96=A <66A E96 5:D62D6 2E 32J] qFE C6D62C496CD C646?E=J 7@F?5 E92E :E鈥橠 >@C6 67764E:G6 E@ DE2CE :>>F?@E96C2AJ 367@C6 DFC86CJ]k^DA2?m kDA2? 4=2DDlQAC:?E0EC:>Qm~?4@=@8:DED 2C6 =@@<:?8 7@C 9:?ED E92E E96 255:E:@? @7 E96 G244:?6 E@ A@DE\DFC86CJ :>>F?@E96C2AJ @776CD 2? 6G6? 3:886C :>AC@G6>6?E[ D2:5 !@DE@H[ H9@ H2D 2? :?G6DE:82E@C :? |6C4<鈥橠 =2E6\DE286 EC:2=]k^DA2?mk^Am kAmp? 6I:DE6?E:2= BF6DE:@? :D H96E96C >#}p\32D65 G244:?6D 42? 92G6 E96 D2>6 :>A24E @? @E96C EJA6D @7 42?46C] |6=2?@>2 :D 4@?D:56C65 @?6 @7 E96 =@H6C\92?8:?8 7CF:ED 7@C :>>F?@E96C2A:6D 3642FD6 E96 EF>@CD 2C6 =:EE6C65 H:E9 >FE2E:@?D[ >2<:?8 E96> 62D:6C 7@C E96 :>>F?6 DJDE6> E@ C64@8?:K6 2D 5:776C6?E 7C@> 962=E9J 46==D 2?5 8@ @? E96 2EE24<] (9:=6 D@>6 @E96C 42?46CD 2C6 <?@H? E@ 36 D:>:=2C=J D6?D:E:G6 E@ EC62E>6?E H:E9 :>>F?@E96C2AJ 鈥 =F?8[ <:5?6J 2?5 46CE2:? <:?5D @7 4@=@? 42?46C[ 7@C 6I2>A=6 鈥 E96 2AAC@249 92D?鈥橢 366? F?:G6CD2==J DF446DD7F=]k^Am kAmkDA2? 4=2DDlQAC:?E0EC:>Qm$E:==[ @?4@=@8:DED 9@A6 42?46C G244:?6D[ H96? 25565 @? E@A @7 @E96C E96C2A:6D[ 4@F=5 3@@DE E96 :>>F?6 DJDE6> 6?@F89 E@ >2<6 2 C62= 5:776C6?46 7@C A2E:6?ED] |6C4< 2?5 |@56C?2 92G6 8@?6 2== :? @? E6DE:?8 E96 E96@CJ[ :?G6DE:?8 :? 2 DH2E9 @7 =2E6\DE286 DEF5:6D :? =F?8[ 3=2556C[ <:5?6J 42?46CD] p?5 @E96CD 2C6 E24<=:?8 EJA:42==J E@F89 EF>@CD[ =:<6 A2?4C62E:4 42?46C[ H:E9 6?4@FC28:?8 C6DF=ED[ 2=36:E 7C@> G6CJ D>2== DEF5:6D]k^DA2?mk^Am kAm~7 4@FCD6[ E96 @E96C BF6DE:@? 92?8:?8 @G6C E9:D @E96CH:D6 8@@5 ?6HD :D H96E96C :E H:== 4@?G:?46 E96 >2?J >65:42= D4:6?46 D<6AE:4D 2?5 4@?DA:C24J E96@C:DED E92E >#}p :D?鈥橢 D@ ?672C:@FD 27E6C 2==] %96 4F=EFC6 H2CD @G6C E96 E649?@=@8J 92G6 2=C625J AFE AC@8C6DD :? 42?46C EC62E>6?E 2E C:D<] xE E@@< 564256D E@ 86E E@ E9:D 25G2?46] xE鈥橠 E:>6 E@ AFE 2D:56 F?7@F?565 A@=:E:42= C96E@C:4 D@ E92E A2E:6?ED 5@?鈥橢 92G6 E@ H2:E D@ =@?8 7@C E96 ?6IE @?6]k^Am Jarvis is a Bloomberg columnist and former executive editor of Chemical & Engineering News. 0 Comments Love 0 Funny 0 Wow 0 Sad 0 Angry 0 Catch the latest in Opinion Get opinion pieces, letters and editorials sent directly to your inbox weekly! Sign up! * I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy. Related to this story Moderna鈥檚 Cancer Vaccine Breakthrough Sends Stocks Soaring Moderna and Merck are celebrating a major milestone after their personalized mRNA cancer treatment succeeded in a late-stage trials.
Moderna鈥檚 Cancer Vaccine Breakthrough Sends Stocks Soaring Moderna and Merck are celebrating a major milestone after their personalized mRNA cancer treatment succeeded in a late-stage trials.
